Literature DB >> 7947037

Transplacental effects of gentamicin on endocytosis in rat renal proximal tubule cells.

H Smaoui1, M Schaeverbeke, J P Mallié, J Schaeverbeke.   

Abstract

Changes in kidney maturation in utero have been reported after gentamicin administration to pregnant rats. While the proteinuria commonly observed could be related to modifications of the glomerular basement membrane, perturbed renal protein handling could be accounted for by changes in the proximal tubular cells. Therefore, we studied the effect of gentamicin on the renal handling and transport of proteins in proximal tubular cells using the horseradish peroxidase, a fluid-phase marker, as a probe. Gentamicin was administered intraperitoneally to pregnant Wistar rats (75 mg/kg body weight per day) and neonatal kidneys were studied 1 day after birth. In proximal tubular cells of the deep cortical area, containing the fully matured nephrons of neonates, the transport and digestion of reabsorbed peroxidase was considerably reduced compared with controls where peroxidase reached lysosomes after endocytosis. Urinary protein excretion increased in treated animals. We conclude that gentamicin, entering the proximal tubular cells via the endocytic pathway, decreases the tubular reabsorption of proteins, thus increasing urinary protein excretion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947037     DOI: 10.1007/bf00856528

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  30 in total

Review 1.  Aminoglycoside nephrotoxicity.

Authors:  H D Humes
Journal:  Kidney Int       Date:  1988-04       Impact factor: 10.612

2.  Placental transfer of gentamicin.

Authors:  H Yoshioka; T Monma; S Matsuda
Journal:  J Pediatr       Date:  1972-01       Impact factor: 4.406

3.  Aminoglycoside nephrotoxicity.

Authors:  G J Kaloyanides; E Pastoriza-Munoz
Journal:  Kidney Int       Date:  1980-11       Impact factor: 10.612

Review 4.  Aminoglycoside nephrotoxicity.

Authors:  W M Bennett
Journal:  Nephron       Date:  1983       Impact factor: 2.847

5.  Differentiation of glomerular filter and tubular reabsorption apparatus during foetal development of the rat kidney.

Authors:  J Schaeverbeke; M Cheignon
Journal:  J Embryol Exp Morphol       Date:  1980-08

6.  Inhibition of kidney lysosomal phospholipases A and C by aminoglycoside antibiotics: possible mechanism of aminoglycoside toxicity.

Authors:  K Y Hostetler; L B Hall
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  Gentamicin administered during gestation alters glomerular basement membrane development.

Authors:  H Smaoui; J P Mallie; M Schaeverbeke; A Robert; J Schaeverbeke
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

8.  Early effects of gentamicin, tobramycin, and amikacin on the human kidney.

Authors:  M E De Broe; G J Paulus; G A Verpooten; F Roels; N Buyssens; R Wedeen; F Van Hoof; P M Tulkens
Journal:  Kidney Int       Date:  1984-04       Impact factor: 10.612

9.  Mechanisms of the defect in glomerular ultrafiltration associated with gentamicin administration.

Authors:  C Baylis; H R Rennke; B M Brenner
Journal:  Kidney Int       Date:  1977-11       Impact factor: 10.612

10.  Autoradiography of gentamicin uptake by the rat proximal tubule cell.

Authors:  F J Silverblatt; C Kuehn
Journal:  Kidney Int       Date:  1979-04       Impact factor: 10.612

View more
  3 in total

Review 1.  Antibacterial-induced nephrotoxicity in the newborn.

Authors:  V Fanos; L Cataldi
Journal:  Drug Saf       Date:  1999-03       Impact factor: 5.606

Review 2.  Effects of maternally administered drugs on the fetal and neonatal kidney.

Authors:  Farid Boubred; Mariella Vendemmia; Patricia Garcia-Meric; Christophe Buffat; Veronique Millet; Umberto Simeoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 3.  Antibiotics in neonatal infections: a review.

Authors:  V Fanos; A Dall'Agnola
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.